The mode of transmission is also unclear, although it is suspected to be through the tonsils or gastrointestinal tract3

The mode of transmission is also unclear, although it is suspected to be through the tonsils or gastrointestinal tract3. active antiretroviral therapy == Introduction == Progressive multifocal leukoencephalopathy (PML), a typically rapidly progressive, potentially fatal neurologic syndrome, was first explained in 1958 as a complication of chronic lymphocytic leukemia and Hodgkins disease1. Within two decades of its initial description, in the 1970s, the JC virus (JCV, also known as JCPyV) was discovered as the etiologic agent2. It is named for a subject with PML patient Steve Cunningham3. Due to its rarity (1. 3 cases Cefoselis sulfate per 1000 person-years at risk in human being immunodeficiency computer virus [HIV]+ patients), the disorder is regarded as an orphan disease4. However , following the acquired immunodeficiency syndrome (AIDS) pandemic and with newer immunomodulatory therapies, such as natalizumab, that predispose to the development of PML, the incidence from the disease has increased substantially. == The JC Virus == A ubiquitous infection, the JCV infects over half of the adult populace globally3, 5, 6. Typically the initial publicity occurs during childhood. Because no recognized clinical illness accompanies acute infection, it is believed that initial contamination results in a transient asymptomatic viremia following which the computer virus establishes as a latent or persistent contamination in the kidney and perhaps elsewhere in the body3. The JCPyV found in the urine of approximately Cefoselis sulfate one-third of all adults is referred to as the archetype virus and is incapable of replicating effectively in glial tissue. It is theorized that the archetypal form of the virus is responsible for the primary contamination. The mode of transmission is also unclear, although it is suspected to be through the tonsils or gastrointestinal tract3. Interestingly, even among the immunocompromised, only a small subset of infected patients develop PML, because the development of this syndrome requires a complex series of events: the virus must be transformed to the prototype (neurotropic) virus, seed the brain, and avoid neuro-immunosurveillance Cefoselis sulfate and clearance. Generally, this occurs in the setting of an impairment in cell-mediated immunity, as with HIV/AIDS, or with the use of immunomodulatory agents, such as natalizumab. The transformation of JCV from the archetype to the prototype computer virus requires genetic modifications in the non-coding control region from the viral DNA. This change of the small , circular JCPyV DNA genome impacts the replicative ability, gene transcription patterns, and homing within the body, and ultimately disease pathology3. == PML and the JC computer virus == In immunocompetent individuals, the JCV is rarely pathogenic, but in immunocompromised patients, it may cause PML, an aggressive, progressive neurologic syndrome that is potentially devastating. Prior to the availability of highly active antiretroviral therapy (HAART), PML was observed in 510% of all persons with AIDS, and HIV/AIDS has been an underlying predisposing cause of PML in more than one-half of individuals3, 7. Following the advent of HAART, the incidence of PML in this populace has declined6. Another cluster of PML cases is observed in patients receiving immunomodulatory therapies. Two therapies in particular appear to predispose to PML, namely natalizumab (trade name Tysabri) and efalizumab (now off the market)8. However , PML has been reported with the use of rituximab, belatacept, fingolimod, infliximab, alemtuzumab, mycophenolate mofetil, fludarabine, leflunomide, and fumaric acid esters as well9. The increased risk of PML from natalizumab is thought to be due to the known mechanism from the drug, namely 41 integrin binding. In so doing, this monoclonal antibody prevents lymphocytes from binding to vascular cell adhesion molecule 1 (VCAM) on the central nervous system (CNS) endothelium, decreasing CNS immune surveillance10. While an immune-modulated state is relatively common, PML remains a rare disorder MMP16 even within these subpopulations. This suggests that immunosuppression only is.